Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Aminu Seman, Adane Mihret, Shemse Sebre, Tewachew Awoke, Biruk Yeshitela, Berhanu Yitayew, Abraham Aseffa, Daniel Asrat & Tamrat Abebe. (2022) Prevalence and Molecular Characterization of Extended Spectrum β-Lactamase and Carbapenemase-Producing Enterobacteriaceae Isolates from Bloodstream Infection Suspected Patients in Addis Ababa, Ethiopia. Infection and Drug Resistance 15, pages 1367-1382.
Read now
Read now
Annika Holmgren, Annika Ljung & Daniel Bremell. (2020) An easy-to-use scoring system for predicting bacteraemia with third-generation cephalosporin-resistant Enterobacterales in a low-resistance setting. Infectious Diseases 52:4, pages 242-248.
Read now
Read now
Sara Thønnings, Filip Jansåker, Kim Oren Gradel, Bjarne Styrishave & Jenny Dahl Knudsen. (2019) Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort. Infection and Drug Resistance 12, pages 1257-1264.
Read now
Read now
Chau-Chyun Sheu, Shang-Yi Lin, Ya-Ting Chang, Chun-Yuan Lee, Yen-Hsu Chen & Po-Ren Hsueh. (2018) Management of infections caused by extended-spectrum β–lactamase-producing Enterobacteriaceae: current evidence and future prospects. Expert Review of Anti-infective Therapy 16:3, pages 205-218.
Read now
Read now
Ilya Nikolaevich Zykov, Arnfinn Sundsfjord, Lars Småbrekke & Ørjan Samuelsen. (2016) The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010–2011. Infectious Diseases 48:2, pages 99-107.
Read now
Read now
Lea Papst, Bojana Beović, Katja Seme & Mateja Pirš. (2015) Two-year prospective evaluation of colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae: time course and risk factors. Infectious Diseases 47:9, pages 618-624.
Read now
Read now
Articles from other publishers (23)
Chan Mi Lee, Shinwon Lee, Eu Suk Kim, Hong Bin Kim, Wan Beom Park, Song Mi Moon, Young Keun Kim, Kyung-Hwa Park, Yee Gyung Kwak, Bongyoung Kim, Yeon Sook Kim, Chung-Jong Kim, Ha-Yeong Gil, Jeonghoon Ahn & Kyoung-Ho Song. (2023) Disease burden of bacteremia with extended-spectrum beta-lactamase-producing and carbapenem-resistant Enterobacteriaceae in Korea. Journal of Hospital Infection.
Crossref
Crossref
H. Namikawa, W. Imoto, K. Yamada, Y. Tochino, Y. Kaneko, H. Kakeya & T. Shuto. (2023) Predictors for onset of extended-spectrum beta-lactamase-producing Escherichia coli-induced bacteraemia: a systematic review and meta-analysis. Journal of Hospital Infection 142, pages 88-95.
Crossref
Crossref
Marco Werhahn Beining, Maria Hartmann, Antina Luebke-Becker, Sebastian Guenther, Katharina Schaufler, Katja Hille & Lothar Kreienbrock. (2023) Carriage of Extended Spectrum Beta Lactamase-Producing Escherichia coli: Prevalence and Factors Associated with Fecal Colonization of Dogs from a Pet Clinic in Lower Saxony, Germany. Animals 13:4, pages 584.
Crossref
Crossref
Ashley Roen, Cynthia Terrones, Wendy Bannister, Marie Helleberg, Michael Asger Andersen, Carsten Utoft Niemann, Gedske Daugaard, Lena Specht, Amanda Mocroft, Joanne Reekie & Jens Lundgren. (2022) Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours. Infection 51:1, pages 147-157.
Crossref
Crossref
Martin Holmbom, Vidar Möller, Loa Kristinsdottir, Maud Nilsson, Mamun-Ur Rashid, Mats Fredrikson, Björn Berglund & Åse Östholm Balkhed. (2022) Risk factors and outcome due to extended-spectrum β-lactamase-producing uropathogenic Escherichia coli in community-onset bloodstream infections: A ten-year cohort study in Sweden. PLOS ONE 17:11, pages e0277054.
Crossref
Crossref
Mohammed Badrul Amin, Kazi Injamamul Hoque, Subarna Roy, Sumita Rani Saha, Md. Rayhanul Islam, Timothy R. Julian & Mohammad Aminul Islam. (2022) Identifying the Sources of Intestinal Colonization With Extended-Spectrum β-Lactamase-Producing Escherichia coli in Healthy Infants in the Community. Frontiers in Microbiology 13.
Crossref
Crossref
Rebecca Wang, Jennifer H. Han, Ebbing Lautenbach, Pranita D. Tamma, Kerri A. Thom, Kevin Alby, Emily A. Blumberg, Warren B. Bilker, Alissa Werzen, Jacqueline Omorogbe, Pam Tolomeo & Judith A. Anesi. (2021) Clinical prediction tool for extended‐spectrum beta‐lactamase‐producing enterobacterales as the etiology of a bloodstream infection in solid organ transplant recipients. Transplant Infectious Disease 23:4.
Crossref
Crossref
Kathryn L McDonald, Sarah Garland, Carolee A Carson, Kimberly Gibbens, E Jane Parmley, Rita Finley & Melissa C MacKinnon. (2021)
Measures used to assess the burden of ESBL-producing
Escherichia coli
infections in humans: a scoping review
. JAC-Antimicrobial Resistance 3:1.
Crossref
Crossref
M. C. MacKinnon, J. M. Sargeant, D. L. Pearl, R. J. Reid-Smith, C. A. Carson, E. J. Parmley & S. A. McEwen. (2020) Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis. Antimicrobial Resistance & Infection Control 9:1.
Crossref
Crossref
Oskar Ljungquist, Angela Camporeale, Shoeib Nematzadeh, Christian G. Giske, Fredrik Resman, Kristian Riesbeck & Johan Tham. (2020)
A Cross-Sectional Cohort Study of Extended-Spectrum-Beta-Lactamase-Producing
Enterobacterales
in Patients with Traveler's Diarrhea
. Antimicrobial Agents and Chemotherapy 64:12.
Crossref
Crossref
Ian A. Brasg, Marion Elligsen, Nick Daneman & Derek R. MacFadden. (2019) Predictive utility of swab screening for extended-spectrum beta-lactamase-producing organisms in selection of empiric antibiotics for Gram-negative sterile-site infections: A retrospective cohort study. Infection Control & Hospital Epidemiology 40:7, pages 823-824.
Crossref
Crossref
Inga Fröding, John Karlsson Valik, Ludvig Bolinder, Pontus Nauclér & Christian G. Giske. (2019) Prediction of bloodstream infection caused by extended-spectrum β-lactamase-producing Enterobacterales in patients with suspected community-onset sepsis. International Journal of Antimicrobial Agents 53:6, pages 820-829.
Crossref
Crossref
Joakim Isendahl, Christian G Giske, Ulf Hammar, Pär Sparen, Karin Tegmark Wisell, Anders Ternhag & Pontus Nauclér. (2019) Temporal Dynamics and Risk Factors for Bloodstream Infection With Extended-spectrum β-Lactamase–producing Bacteria in Previously-colonized Individuals: National Population-based Cohort Study. Clinical Infectious Diseases 68:4, pages 641-649.
Crossref
Crossref
Moonsuk Kim, Kyoung-Ho Song, Chung-Jong Kim, Pyoeng Gyun Choe, Wan Beom Park, Ji Hwan Bang, Eu Suk Kim, Sang-Won Park, Nam Joong Kim, Myoung-don Oh & Hong Bin Kim. (2019)
Clinical Prediction Score for Community-Onset Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing
Escherichia coli
and
Klebsiella
Species
. Journal of Korean Medical Science 34:14.
Crossref
Crossref
Sofia Ny, Roman Kozlov, Uga Dumpis, Petra Edquist, Kirsi Gröndahl-Yli-Hannuksela, Anna-Maria Kling, Danuta O. Lis, Christoph Lübbert, Monika Pomorska-Wesołowska, Ivan Palagin, Aija Vilde, Jaana Vuopio, Jan Walter & Karin Tegmark Wisell. (2018) Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia. European Journal of Clinical Microbiology & Infectious Diseases 37:12, pages 2347-2354.
Crossref
Crossref
Hyeonseok Lee, Seung Baik Han, Ji Hye Kim, Soo Kang & Areum Durey. (2018) Risk factors of urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli in emergency department. The American Journal of Emergency Medicine 36:9, pages 1608-1612.
Crossref
Crossref
Vered Daitch, Yulia Akayzen, Yasmin Abu-Ghanem, Noa Eliakim-Raz, Mical Paul, Leonard Leibovici & Dafna Yahav. (2018) Secular trends in the appropriateness of empirical antibiotic treatment in patients with bacteremia: a comparison between three prospective cohorts. European Journal of Clinical Microbiology & Infectious Diseases 37:3, pages 455-462.
Crossref
Crossref
Taro Noguchi, Yasufumi Matsumura, Masaki Yamamoto, Miki Nagao, Shunji Takakura & Satoshi Ichiyama. (2017) Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study. BMC Infectious Diseases 17:1.
Crossref
Crossref
M Cristina Vazquez-Guillamet, Rodrigo Vazquez, Scott T Micek & Marin H Kollef. (2017) Predicting Resistance to Piperacillin-Tazobactam, Cefepime and Meropenem in Septic Patients With Bloodstream Infection Due to Gram-Negative Bacteria. Clinical Infectious Diseases 65:10, pages 1607-1614.
Crossref
Crossref
Lisa Jacmel, Sandra Timsit, Agnès Ferroni, Clémentine Auregan, François Angoulvant & Gérard Chéron. (2017)
Extended-spectrum
β
-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre
. Acta Paediatrica 106:1, pages 142-147.
Crossref
Crossref
Andreas Blom, Jonas Ahl, Fredrik Månsson, Fredrik Resman & Johan Tham. (2016) The prevalence of ESBL-producing Enterobacteriaceae in a nursing home setting compared with elderly living at home: a cross-sectional comparison. BMC Infectious Diseases 16:1.
Crossref
Crossref
Katherine E. Goodman, Justin Lessler, Sara E. Cosgrove, Anthony D. Harris, Ebbing Lautenbach, Jennifer H. Han, Aaron M. Milstone, Colin J. Massey & Pranita D. Tamma. (2016) A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum β-Lactamase–Producing Organism. Clinical Infectious Diseases 63:7, pages 896-903.
Crossref
Crossref
Margaret A. Fitzpatrick, Katie J. Suda, Nasia Safdar, Barry Goldstein, Makoto M. Jones, Linda Poggensee, Swetha Ramanathan, Ryan LeWan & Charlesnika T. Evans. (2016)
Unique Risks and Clinical Outcomes Associated With Extended-Spectrum β-Lactamase
Enterobacteriaceae
in Veterans With Spinal Cord Injury or Disorder: A Case-Case-Control Study
. Infection Control & Hospital Epidemiology 37:7, pages 768-776.
Crossref
Crossref